Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment

ABSTRACT: Introduction and aim: Epidemiological information regarding drug-induced liver injury in some Latin American countries remains limited. Therefore, disease prevention and health promotion strategies are imperative to reduce drug-induced liver injuries and its fatal outcomes. This study aime...

Full description

Autores:
Amariles Muñoz, Pedro
Cano Paniagua, Alejandra
Restrepo Garay, Margarita María
Angulo, Nancy
Tipo de recurso:
Article of investigation
Fecha de publicación:
2019
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/40144
Acceso en línea:
https://hdl.handle.net/10495/40144
Palabra clave:
Anciano
Aged
Anciano de 80 o más Años
Aged, 80 and over
Alanina Transaminasa - metabolismo
Alanine Transaminase - metabolism
Fosfatasa Alcalina - metabolismo
Alkaline Phosphatase - metabolism
Biomarcadores - metabolismo
Biomarkers - metabolism
Enfermedad Hepática Inducida por Sustancias y Drogas - diagnóstico
Chemical and Drug Induced Liver Injury - diagnosis
Enfermedad Hepática Inducida por Sustancias y Drogas - epidemiología
Chemical and Drug Induced Liver Injury - epidemiology
Colombia - epidemiología
Colombia - epidemiology
Estudios de Seguimiento
Follow-Up Studies
Hospitalización - estadística & datos numéricos
Hospitalization - statistics & numerical data
Hospitales Universitarios - estadística & datos numéricos
Hospitals, University - statistics & numerical data
Incidencia
Incidence
Hígado
Liver
Pruebas de Función Hepática
Liver Function Tests
Persona de Mediana Edad
Middle Aged
Pronóstico
Prognosis
Estudios Prospectivos
Prospective Studies
Medición de Riesgo - métodos
Risk Assessment - methods
Factores de Riesgo
Risk Factors
Adulto Joven
Young Adult
https://id.nlm.nih.gov/mesh/D000368
https://id.nlm.nih.gov/mesh/D000369
https://id.nlm.nih.gov/mesh/D000410
https://id.nlm.nih.gov/mesh/D000469
https://id.nlm.nih.gov/mesh/D015415
https://id.nlm.nih.gov/mesh/D056486
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D005500
https://id.nlm.nih.gov/mesh/D006760
https://id.nlm.nih.gov/mesh/D006785
https://id.nlm.nih.gov/mesh/D015994
https://id.nlm.nih.gov/mesh/D008099
https://id.nlm.nih.gov/mesh/D008111
https://id.nlm.nih.gov/mesh/D008875
https://id.nlm.nih.gov/mesh/D011379
https://id.nlm.nih.gov/mesh/D011446
https://id.nlm.nih.gov/mesh/D018570
https://id.nlm.nih.gov/mesh/D012307
https://id.nlm.nih.gov/mesh/D055815
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/4.0/
id UDEA2_24c99c047a92964f6c3fe7a653719cc3
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/40144
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment
title Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment
spellingShingle Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment
Anciano
Aged
Anciano de 80 o más Años
Aged, 80 and over
Alanina Transaminasa - metabolismo
Alanine Transaminase - metabolism
Fosfatasa Alcalina - metabolismo
Alkaline Phosphatase - metabolism
Biomarcadores - metabolismo
Biomarkers - metabolism
Enfermedad Hepática Inducida por Sustancias y Drogas - diagnóstico
Chemical and Drug Induced Liver Injury - diagnosis
Enfermedad Hepática Inducida por Sustancias y Drogas - epidemiología
Chemical and Drug Induced Liver Injury - epidemiology
Colombia - epidemiología
Colombia - epidemiology
Estudios de Seguimiento
Follow-Up Studies
Hospitalización - estadística & datos numéricos
Hospitalization - statistics & numerical data
Hospitales Universitarios - estadística & datos numéricos
Hospitals, University - statistics & numerical data
Incidencia
Incidence
Hígado
Liver
Pruebas de Función Hepática
Liver Function Tests
Persona de Mediana Edad
Middle Aged
Pronóstico
Prognosis
Estudios Prospectivos
Prospective Studies
Medición de Riesgo - métodos
Risk Assessment - methods
Factores de Riesgo
Risk Factors
Adulto Joven
Young Adult
https://id.nlm.nih.gov/mesh/D000368
https://id.nlm.nih.gov/mesh/D000369
https://id.nlm.nih.gov/mesh/D000410
https://id.nlm.nih.gov/mesh/D000469
https://id.nlm.nih.gov/mesh/D015415
https://id.nlm.nih.gov/mesh/D056486
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D005500
https://id.nlm.nih.gov/mesh/D006760
https://id.nlm.nih.gov/mesh/D006785
https://id.nlm.nih.gov/mesh/D015994
https://id.nlm.nih.gov/mesh/D008099
https://id.nlm.nih.gov/mesh/D008111
https://id.nlm.nih.gov/mesh/D008875
https://id.nlm.nih.gov/mesh/D011379
https://id.nlm.nih.gov/mesh/D011446
https://id.nlm.nih.gov/mesh/D018570
https://id.nlm.nih.gov/mesh/D012307
https://id.nlm.nih.gov/mesh/D055815
title_short Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment
title_full Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment
title_fullStr Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment
title_full_unstemmed Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment
title_sort Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment
dc.creator.fl_str_mv Amariles Muñoz, Pedro
Cano Paniagua, Alejandra
Restrepo Garay, Margarita María
Angulo, Nancy
dc.contributor.author.none.fl_str_mv Amariles Muñoz, Pedro
Cano Paniagua, Alejandra
Restrepo Garay, Margarita María
Angulo, Nancy
dc.contributor.researchgroup.spa.fl_str_mv Promoción y Prevención Farmacéutica
dc.subject.decs.none.fl_str_mv Anciano
Aged
Anciano de 80 o más Años
Aged, 80 and over
Alanina Transaminasa - metabolismo
Alanine Transaminase - metabolism
Fosfatasa Alcalina - metabolismo
Alkaline Phosphatase - metabolism
Biomarcadores - metabolismo
Biomarkers - metabolism
Enfermedad Hepática Inducida por Sustancias y Drogas - diagnóstico
Chemical and Drug Induced Liver Injury - diagnosis
Enfermedad Hepática Inducida por Sustancias y Drogas - epidemiología
Chemical and Drug Induced Liver Injury - epidemiology
Colombia - epidemiología
Colombia - epidemiology
Estudios de Seguimiento
Follow-Up Studies
Hospitalización - estadística & datos numéricos
Hospitalization - statistics & numerical data
Hospitales Universitarios - estadística & datos numéricos
Hospitals, University - statistics & numerical data
Incidencia
Incidence
Hígado
Liver
Pruebas de Función Hepática
Liver Function Tests
Persona de Mediana Edad
Middle Aged
Pronóstico
Prognosis
Estudios Prospectivos
Prospective Studies
Medición de Riesgo - métodos
Risk Assessment - methods
Factores de Riesgo
Risk Factors
Adulto Joven
Young Adult
topic Anciano
Aged
Anciano de 80 o más Años
Aged, 80 and over
Alanina Transaminasa - metabolismo
Alanine Transaminase - metabolism
Fosfatasa Alcalina - metabolismo
Alkaline Phosphatase - metabolism
Biomarcadores - metabolismo
Biomarkers - metabolism
Enfermedad Hepática Inducida por Sustancias y Drogas - diagnóstico
Chemical and Drug Induced Liver Injury - diagnosis
Enfermedad Hepática Inducida por Sustancias y Drogas - epidemiología
Chemical and Drug Induced Liver Injury - epidemiology
Colombia - epidemiología
Colombia - epidemiology
Estudios de Seguimiento
Follow-Up Studies
Hospitalización - estadística & datos numéricos
Hospitalization - statistics & numerical data
Hospitales Universitarios - estadística & datos numéricos
Hospitals, University - statistics & numerical data
Incidencia
Incidence
Hígado
Liver
Pruebas de Función Hepática
Liver Function Tests
Persona de Mediana Edad
Middle Aged
Pronóstico
Prognosis
Estudios Prospectivos
Prospective Studies
Medición de Riesgo - métodos
Risk Assessment - methods
Factores de Riesgo
Risk Factors
Adulto Joven
Young Adult
https://id.nlm.nih.gov/mesh/D000368
https://id.nlm.nih.gov/mesh/D000369
https://id.nlm.nih.gov/mesh/D000410
https://id.nlm.nih.gov/mesh/D000469
https://id.nlm.nih.gov/mesh/D015415
https://id.nlm.nih.gov/mesh/D056486
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D005500
https://id.nlm.nih.gov/mesh/D006760
https://id.nlm.nih.gov/mesh/D006785
https://id.nlm.nih.gov/mesh/D015994
https://id.nlm.nih.gov/mesh/D008099
https://id.nlm.nih.gov/mesh/D008111
https://id.nlm.nih.gov/mesh/D008875
https://id.nlm.nih.gov/mesh/D011379
https://id.nlm.nih.gov/mesh/D011446
https://id.nlm.nih.gov/mesh/D018570
https://id.nlm.nih.gov/mesh/D012307
https://id.nlm.nih.gov/mesh/D055815
dc.subject.meshuri.none.fl_str_mv https://id.nlm.nih.gov/mesh/D000368
https://id.nlm.nih.gov/mesh/D000369
https://id.nlm.nih.gov/mesh/D000410
https://id.nlm.nih.gov/mesh/D000469
https://id.nlm.nih.gov/mesh/D015415
https://id.nlm.nih.gov/mesh/D056486
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D005500
https://id.nlm.nih.gov/mesh/D006760
https://id.nlm.nih.gov/mesh/D006785
https://id.nlm.nih.gov/mesh/D015994
https://id.nlm.nih.gov/mesh/D008099
https://id.nlm.nih.gov/mesh/D008111
https://id.nlm.nih.gov/mesh/D008875
https://id.nlm.nih.gov/mesh/D011379
https://id.nlm.nih.gov/mesh/D011446
https://id.nlm.nih.gov/mesh/D018570
https://id.nlm.nih.gov/mesh/D012307
https://id.nlm.nih.gov/mesh/D055815
description ABSTRACT: Introduction and aim: Epidemiological information regarding drug-induced liver injury in some Latin American countries remains limited. Therefore, disease prevention and health promotion strategies are imperative to reduce drug-induced liver injuries and its fatal outcomes. This study aimed to collect epidemiological data regarding drug-induced liver injury and identify associated factors in patients admitted to a university hospital in Colombia. Methods and patients: A prospective study was conducted for 1 year to assess the incidence of druginduced liver injury in patients aged >18 years who showed elevated values in liver tests. Data were collected after obtaining informed consentfrom the patients. The updated Roussel Uclaf Causality Assessment Method was applied to assess the causality of drug-induced liver injury. Results: The study included 286 patients with elevated values in liver tests, 18 of whom presented with drug-induced liver injury. The mean age of patients was 54.7 ± 19.1 years. The associated pharmacological groups were anti-infectives and anticonvulsants (isoniazid, rifampicin, nitrofurantoin, phenytoin, and valproic acid), with a total of 15 drugs. The affected patients presented with cytopenia, jaundice, nausea, vomiting, or hepatomegaly. The most common type of liver injury was hepatocellular, and most patients recovered satisfactorily. The number of patients who had highly probable and probable causality grading was 1 and 9, respectively. Conclusion: The incidence of drug-induced liver injury in a university hospital in Colombia was 6%. Comorbidities and concomitant drugs are risk factors for drug-induced liver injury.
publishDate 2019
dc.date.issued.none.fl_str_mv 2019
dc.date.accessioned.none.fl_str_mv 2024-06-19T14:44:38Z
dc.date.available.none.fl_str_mv 2024-06-19T14:44:38Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.issn.none.fl_str_mv 1665-2681
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/40144
dc.identifier.doi.none.fl_str_mv 10.1016/j.aohep.2018.11.008
dc.identifier.eissn.none.fl_str_mv 2659-5982
identifier_str_mv 1665-2681
10.1016/j.aohep.2018.11.008
2659-5982
url https://hdl.handle.net/10495/40144
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Ann. Hepatol.
dc.relation.citationendpage.spa.fl_str_mv 507
dc.relation.citationissue.spa.fl_str_mv 3
dc.relation.citationstartpage.spa.fl_str_mv 501
dc.relation.citationvolume.spa.fl_str_mv 18
dc.relation.ispartofjournal.spa.fl_str_mv Annals of Hepatology
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 7 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Asociación Mexicana de Hepatología
Elsevier
dc.publisher.place.spa.fl_str_mv Ciudad de México, México
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/84beb716-7aa8-4956-81c2-2bb770b76857/download
https://bibliotecadigital.udea.edu.co/bitstreams/939ee51c-c857-4876-a192-c48b0feda84a/download
https://bibliotecadigital.udea.edu.co/bitstreams/a3214070-77b5-487f-b533-a7c354ce8103/download
https://bibliotecadigital.udea.edu.co/bitstreams/3b7b4cc2-cbd5-4c4d-89e4-fdcc3aee4c0a/download
https://bibliotecadigital.udea.edu.co/bitstreams/aa4de5f7-e215-419a-8d0b-e88bf91ab5dd/download
bitstream.checksum.fl_str_mv aa531f70dfea0244b1d5deb59e96896f
b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
4ef963986b2ead7910036948a310c260
b6e9004377b2449a660d24041ae7e3b2
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052339904905216
spelling Amariles Muñoz, PedroCano Paniagua, AlejandraRestrepo Garay, Margarita MaríaAngulo, NancyPromoción y Prevención Farmacéutica2024-06-19T14:44:38Z2024-06-19T14:44:38Z20191665-2681https://hdl.handle.net/10495/4014410.1016/j.aohep.2018.11.0082659-5982ABSTRACT: Introduction and aim: Epidemiological information regarding drug-induced liver injury in some Latin American countries remains limited. Therefore, disease prevention and health promotion strategies are imperative to reduce drug-induced liver injuries and its fatal outcomes. This study aimed to collect epidemiological data regarding drug-induced liver injury and identify associated factors in patients admitted to a university hospital in Colombia. Methods and patients: A prospective study was conducted for 1 year to assess the incidence of druginduced liver injury in patients aged >18 years who showed elevated values in liver tests. Data were collected after obtaining informed consentfrom the patients. The updated Roussel Uclaf Causality Assessment Method was applied to assess the causality of drug-induced liver injury. Results: The study included 286 patients with elevated values in liver tests, 18 of whom presented with drug-induced liver injury. The mean age of patients was 54.7 ± 19.1 years. The associated pharmacological groups were anti-infectives and anticonvulsants (isoniazid, rifampicin, nitrofurantoin, phenytoin, and valproic acid), with a total of 15 drugs. The affected patients presented with cytopenia, jaundice, nausea, vomiting, or hepatomegaly. The most common type of liver injury was hepatocellular, and most patients recovered satisfactorily. The number of patients who had highly probable and probable causality grading was 1 and 9, respectively. Conclusion: The incidence of drug-induced liver injury in a university hospital in Colombia was 6%. Comorbidities and concomitant drugs are risk factors for drug-induced liver injury.Universidad de Antioquia. Vicerrectoría de investigación. Comité para el Desarrollo de la Investigación - CODICOL00746617 páginasapplication/pdfengAsociación Mexicana de HepatologíaElsevierCiudad de México, Méxicohttps://creativecommons.org/licenses/by-nc-nd/4.0/http://creativecommons.org/licenses/by-nc-nd/2.5/co/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessmentArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAncianoAgedAnciano de 80 o más AñosAged, 80 and overAlanina Transaminasa - metabolismoAlanine Transaminase - metabolismFosfatasa Alcalina - metabolismoAlkaline Phosphatase - metabolismBiomarcadores - metabolismoBiomarkers - metabolismEnfermedad Hepática Inducida por Sustancias y Drogas - diagnósticoChemical and Drug Induced Liver Injury - diagnosisEnfermedad Hepática Inducida por Sustancias y Drogas - epidemiologíaChemical and Drug Induced Liver Injury - epidemiologyColombia - epidemiologíaColombia - epidemiologyEstudios de SeguimientoFollow-Up StudiesHospitalización - estadística & datos numéricosHospitalization - statistics & numerical dataHospitales Universitarios - estadística & datos numéricosHospitals, University - statistics & numerical dataIncidenciaIncidenceHígadoLiverPruebas de Función HepáticaLiver Function TestsPersona de Mediana EdadMiddle AgedPronósticoPrognosisEstudios ProspectivosProspective StudiesMedición de Riesgo - métodosRisk Assessment - methodsFactores de RiesgoRisk FactorsAdulto JovenYoung Adulthttps://id.nlm.nih.gov/mesh/D000368https://id.nlm.nih.gov/mesh/D000369https://id.nlm.nih.gov/mesh/D000410https://id.nlm.nih.gov/mesh/D000469https://id.nlm.nih.gov/mesh/D015415https://id.nlm.nih.gov/mesh/D056486https://id.nlm.nih.gov/mesh/D003105https://id.nlm.nih.gov/mesh/D005500https://id.nlm.nih.gov/mesh/D006760https://id.nlm.nih.gov/mesh/D006785https://id.nlm.nih.gov/mesh/D015994https://id.nlm.nih.gov/mesh/D008099https://id.nlm.nih.gov/mesh/D008111https://id.nlm.nih.gov/mesh/D008875https://id.nlm.nih.gov/mesh/D011379https://id.nlm.nih.gov/mesh/D011446https://id.nlm.nih.gov/mesh/D018570https://id.nlm.nih.gov/mesh/D012307https://id.nlm.nih.gov/mesh/D055815Ann. Hepatol.507350118Annals of HepatologyConvocatorias de Sostenibilidad 2018–2019RoR:03bp5hc83PublicationORIGINALAmarilesPedro_2019_Epidemiology_Drug-Induced.pdfAmarilesPedro_2019_Epidemiology_Drug-Induced.pdfArtículo de investigaciónapplication/pdf889237https://bibliotecadigital.udea.edu.co/bitstreams/84beb716-7aa8-4956-81c2-2bb770b76857/downloadaa531f70dfea0244b1d5deb59e96896fMD51trueAnonymousREADCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstreams/939ee51c-c857-4876-a192-c48b0feda84a/downloadb88b088d9957e670ce3b3fbe2eedbc13MD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/a3214070-77b5-487f-b533-a7c354ce8103/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADTEXTAmarilesPedro_2019_Epidemiology_Drug-Induced.pdf.txtAmarilesPedro_2019_Epidemiology_Drug-Induced.pdf.txtExtracted texttext/plain100230https://bibliotecadigital.udea.edu.co/bitstreams/3b7b4cc2-cbd5-4c4d-89e4-fdcc3aee4c0a/download4ef963986b2ead7910036948a310c260MD54falseAnonymousREADTHUMBNAILAmarilesPedro_2019_Epidemiology_Drug-Induced.pdf.jpgAmarilesPedro_2019_Epidemiology_Drug-Induced.pdf.jpgGenerated Thumbnailimage/jpeg14717https://bibliotecadigital.udea.edu.co/bitstreams/aa4de5f7-e215-419a-8d0b-e88bf91ab5dd/downloadb6e9004377b2449a660d24041ae7e3b2MD55falseAnonymousREAD10495/40144oai:bibliotecadigital.udea.edu.co:10495/401442025-03-26 20:50:18.665https://creativecommons.org/licenses/by-nc-nd/4.0/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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